Fahri Saatcioglu

Bilde av Fahri Saatcioglu
English version of this page
Telefon +47 22854569
Rom 3611
Brukernavn
Besøksadresse Blindernveien 31 0371 Oslo
Postadresse Postboks 1066 Blindern 0316 Oslo

Research Interests

The goal of the studies in our laboratory is to understand how androgens, male sex hormones, exert their effects on the normal physiology, as well as their role in disease states. Androgens bind to an intracellular receptor, called the androgen receptor (AR), that belongs to a superfamily of ligand-activated transcription factors, called nuclear receptors, which bring about changes in the phenotype of the cell through modulation of gene expression. To understand this process, we are using molecular, biochemical, cell biological and genetic approaches. Since androgens and AR have a significant role in prostate cancer, this work is also relevant for identification and validation of biomarkers or therapeutic targets for prostate cancer.


Teaching

MBV 3020 Genetics and developmental biology
MBV 3090 Research literature in cancer biology


Academic appointments

1/2013-Present       Professor, Dept. of Biosciences, University of Oslo
1/2002-12/2012      Professor, Dept. of Molecular Biosciences, University of Oslo
10/2000-Present     Visiting Scientist, Harvard School of Public Health, Boston, USA
02/2011-Present     Researcher (20%), Institute for Medical Informatics, Division of Surgery and Cancer Medicine, Oslo University Hospital, Oslo, Norway
11/2009-08/2010    Sabbatical, Harvard School of Public Health, Boston, USA
10/2000-11/2001    Sabbatical, Harvard School of Public Health, Boston, USA
7/1996-12/2001      Group Leader, Biotechnology Centre of Oslo, University of Oslo
10/1993-4/1996      Assistant Research Molecular Biologist, Department of Pharmacology, School of Medicine, University of California, San Diego, CA, USA
9/1990-9/1993        Post-doctoral fellow, Department of Pharmacology, School of Medicine, University of California, San Diego, CA, USA
3/1990-7/1990        Visiting scientist, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA


Honors and distinctions

2009-2012      Special Cancer Program Award, Norwegian Research Council
2004-2007      Top Researcher Award, Norwegian Research Council
2004-2007       Special Cancer Program Award, Norwegian Research Council
2001-2003      Top Researcher Award, Norwegian Research Council
2000-2003      Special Cancer Program Award, Norwegian Research Council
1995-1996      ACS Institutional Fellowship, University of California, San Diego
1994-1995      Research Committee Award, University of California, San Diego
1993-1995       New Investigator Award, AIDS Related Disease Research Program, University of California
1992-1993       Post-doctoral fellowship, American Heart Association
1990-1992       Post-doctoral fellowship, Tobacco Related Disease Research Program, University of California
1987, 89, 90    Visiting Scientist Fellowship, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA (3-12 weeks at a time)
1987, 7-11       Visiting Researcher, Laboratory of Experimental Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD
1985                Salutatorian of the graduating class


Committees

Ad hoc grant review committees: Cancer Research UK; Prostate Cancer Charity UK; Australia Research Council; European Research Council. Member, Senior Editorial Board, American J. of Cancer Research, 2010-2013. Ad hoc reviewer for several international refereed journals, including Nature Reviews Cancer, Cancer Research, Clinical Cancer Research, Oncogene, J. of Pathology, Int. J. of Cancer, J. of Urology, Neoplasia, Tumor Biology, BMC Molecular Biology, Endocrine Related Cancer, Thrombosis and Haemostasis. Director, PhD Program, IMBV, University of Oslo, 2006-present. Advisor to eight PhD and 15 MSc students who have successfully completed their degrees, trained 6 postdoctoral fellows. Currently advisor for 3 PhD and 3 MSc students, and 2 postdoctoral fellows.

 

Current collaborations

University of Oslo
Oslo University Hospital
Cancer Registry of Norway
Umeå University, Sweden
Gothenborg University, Sweden
Lund University, Sweden
University of Porto, Portugal
Harvard University, USA
National Institutes of Health, USA
MD Andersen Cancer Center, USA
Vancouver Prostate Cancer, Canada

 

Emneord: Cell Signaling and Cancer
Publisert 4. nov. 2010 14:47 - Sist endret 24. aug. 2018 11:55

Prosjekter

Ingen pågående prosjekter